From the Institute of Biochemistry, Swiss Federal Institute of Technology, ETH-Hoenggerberg, Zurich, Switzerland; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland; Department of Dermatology, Inselspital, Berne, Switzerland; Robert Koch Institut, Berlin, Germany; and ZLB Bioplasma, Berne, Switzerland.
Intravenously applied normal human immunoglobulin G (IgG) has anti-inflammatory effects in the treatment of autoimmune diseases. Systemic inflammation can originate from an overreacting amplification loop of the complement system. In blood, C3b2-containing complexes maintain complement amplification much better than the extremely short-lived C3b. Therefore, in patients with the complement-dependent autoimmune disease, dermatomyositis, we studied whether intravenously applied normal human IgG (IVIG) stimulated in vivo inactivation of these complexes. In the course of IVIG treatment, clinically effective in 6 of 8 patients, the concentration of C3b2-containing complexes dropped to 37% ± 14% (n = 6) of the pretreatment level when having infused 0.5 g IgG/kg body weight, increased marginally and in parallel to factor Bb thereafter until full-dose IgG was infused. By day 14 following infusion of 2 g IgG/kg body weight the concentration of C3b2-containing complexes was 66% ± 19%. The plasma concentration of C3 remained constant in myopathic or increased by 15% to 20% in amyopathic patients. In contrast to this, IVIG infusion was associated with consumption of up to 40% of plasma C4 at day 1 to 2 after completion of IVIG infusion. Thus, IVIG had an immediate and long-lasting attenuating effect on complement amplification in vivo, despite the fact that it induced classical complement pathway activation.
Interleukin-6–Deficient Mice Resist Development of Autoimmune Myocarditis Associated With Impaired Upregulation of Complement C3
Complement C3 and C-Reactive Protein Are Elevated in South Asians Independent of a Family History of Stroke
Loss of Red Blood CellComplement Regulatory Proteins and Increased Levels of Circulating Immune Complexes Are Associated with Severe Malarial Anemia
Differential Regulation of Endothelial Cell Activation by Complement and Interleukin 1
Complement Activation in Angiotensin IIeCInduced Organ Damage
HIV-1 incorporates ABO histo-blood group antigens that sensitize virions to complement-mediated inactivation
Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP–sialic acid transporter
Bone Morphogenetic Protein-15 in the Zebrafish Ovary: Complementary Deoxyribonucleic Acid Cloning, Genomic Organization, Tissue Distribution, and Role in Oocyte Maturation
A Yin-Yang Effect between Sex Chromosome Complement and Sex Hormones on the Immune Response
Complement C3 Is a Risk Factor for the Development of Diabetes